Rock Steady but Fragile: Will Biohacking Sting Big Pharma to Death?

This time is different – this is a start that the reader might think Carmen Reinhart and Kenneth Rogoff could begin with – and yes, this time the reader really faces a new writer instead of the Ultra High-Frequency Trading oriented academic behind the pen name 7/.V. In due arithmetic progression, let’s call me 8RD+, […]

Advertisement

Read more "Rock Steady but Fragile: Will Biohacking Sting Big Pharma to Death?"